Holen Sie sich die Stockscreener-App
209.84
0.88%
1.83
Handel nachbörslich:
209.84
Insulet Corporation Aktie (PODD) Neueste Nachrichten
Winners And Losers Of Q4: Insulet (NASDAQ:PODD) Vs The Rest Of The Patient Monitoring Stocks - finance.yahoo.com
Zevenbergen Capital Investments LLC Invests $32.14 Million in Insulet Corporation $PODD - MarketBeat
Insulet (NASDAQ:PODD) Reaches New 12-Month LowTime to Sell? - MarketBeat
Insulet Earnings: Stellar Finish to 2025 With Strong Fourth Quarter - Morningstar
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Insulet Corporation (PODD) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Truist maintains Insulet Corporation (PODD) buy rating despite device correction announcement - MSN
Insulet Corp. Stock Hits New 52-Week Low at USD 215.26 - Markets Mojo
Consumer safety roundup: Major recalls affect Einstein Bros., Insulet, Amneal and Falcon Trading - washingtontimes.com
Insulet Corp (PODD) Shares Down 4.53% on Mar 30 - GuruFocus
Is Insulet’s (PODD) New CCO Hire a Subtle Reset of Its Global Commercial Strategy? - simplywall.st
Insulet names Mike Panos as chief commercial officer By Investing.com - Investing.com Canada
Insulet Corporation Appoints Mike Panos as Executive Vice President and Chief Commercial Officer, Effective March 30, 2026 - marketscreener.com
Insulet names Mike Panos as chief commercial officer - Investing.com
Insulet Appoints Mike Panos as Chief Commercial Officer - Bakersfield.com
Insulet Reports Improved EVOLUTION 2C Trial Outcomes - Let's Data Science
SG Americas Securities LLC Purchases 36,570 Shares of Insulet Corporation $PODD - MarketBeat
Beacon Investment Advisory Services Inc. Cuts Position in Insulet Corporation $PODD - MarketBeat
Insulet recalling certain defective Omnipod insulin delivery devices - MSN
PODD Investors Have Opportunity to Join Insulet Corporation Fraud Investigation with the Schall Law Firm - Business Wire
Is Insulet stock underperforming the Dow? - MSN
Insulet Corp. stock underperforms Friday when compared to competitors - MarketWatch
Align Technology, QuidelOrtho, DexCom, Insulet, and Omnicell Shares Are Falling, What You Need To Know - finance.yahoo.com
2026-03-27 | Insulet Corporation (PODD) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | NDAQ:PODD | Press Release - Stockhouse
Vanguard (PODD) parent reports 0 shares after realignment; subsidiaries to report - Stock Titan
Insulet (PODD) down 8.2% since last earnings report: Can it rebound? - MSN
Jayme Wilson joins Brunson, Insulet Corporation hires Cameron Yung, Ashley Csanady promoted at McMillan Vantage - ipolitics.ca
Bronstein, Gewirtz & Grossman, LLC Is Investigating Insulet Corporation (PODD) And Encourages Investors to Connect - ACCESS Newswire
Insulet Trials Closed Loop Pod For Type 2 Diabetes As Shares Lag - Sahm
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insulet CorporationPODD - PR Newswire
PODD Investor Alert: Insulet Corp. Potential Securities Fraud LawsuitInvestors With Losses May Seek to Lead the Class Action After Executives Allegedly Misled on Safety: Levi & Korsinsky - GlobeNewswire
Bronstein, Gewirtz & Grossman, LLC Encourages Insulet Corporation (PODD) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Insulet Corporation stock hits 52-week low at $216.12 By Investing.com - Investing.com India
Insulet stock hits 52-week low amid Omnipod 5 defect probe and class action scrutiny - AD HOC NEWS
Published on: 2026-03-26 06:50:47 - baoquankhu1.vn
Insulet Corp. stock underperforms Wednesday when compared to competitors - MSN
Insulet (NASDAQ:PODD) Hits New 12-Month LowShould You Sell? - MarketBeat
Insulet stock faces securities fraud probe pressure after Omnipod 5 pod recall and sharp NASDAQ decl - AD HOC NEWS
Insulet slides as investors weigh Omnipod 5 device correction and potential 2026 costs - quiverquant.com
Insulet Corporation stock hits 52-week low at $216.12 - Investing.com
Is Insulet (PODD) Pricing Reflect Its Recent Share Pullback And DCF Implied Upside Potential - Sahm
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Insulet Corporation (PODD) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Diversified Trust Co. Purchases 6,742 Shares of Insulet Corporation $PODD - MarketBeat
Assenagon Asset Management S.A. Buys 24,761 Shares of Insulet Corporation $PODD - MarketBeat
Insulet stock faces pressure amid investor probe and recent share pullback on NASDAQ - AD HOC NEWS
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insulet ... - Bluefield Daily Telegraph
Omnipod Recall Lawsuit - AboutLawsuits.com
Insulet OmniPod 5 Recall Lawsuits May Be Filed Over Problems Resulting in Diabetic Ketoacidosis, Hospitalization and Death - AboutLawsuits.com
PODD SEC FilingsInsulet Corp 10-K, 10-Q, 8-K Forms - Stock Titan
M & L Capital Management Ltd Purchases Shares of 5,630 Insulet Corporation $PODD - MarketBeat
PODD Stock Price, Quote & Chart | INSULET CORP (NASDAQ:PODD) - ChartMill
Insulet Corporation (PODD) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - accessnewswire.com
Gradient Investments LLC Purchases 10,497 Shares of Insulet Corporation $PODD - MarketBeat
Insulet Corporation $PODD Shares Bought by Nordea Investment Management AB - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Insulet Corporation (PODD) And Encourages Stockholders to Reach Out - ACCESS Newswire
Insulet Corporation $PODD Shares Sold by Swiss Life Asset Management Ltd - MarketBeat
Insulet Stock Faces Headwinds Amid Diabetes Tech Slowdown and Market Pressures - AD HOC NEWS
Hudson Bay Capital Management LP Takes Position in Insulet Corporation $PODD - MarketBeat
2.03%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):